ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2021

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers.

Igor Odintsov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.